| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $4.6B | $1.1B | $1.1B | $1.1B | $1.0B | $0.9B | $0.9B | $0.9B |
| Cost of Revenue | $3.2B | $0.7B | $0.8B | $3.2B | $3.0B | $2.5B | $2.6B | $2.5B |
| Gross Profit | — | — | — | $0.3B | $0.2B | $0.2B | $0.3B | $0.3B |
| R&D Expense | — | — | — | — | — | — | $0.0B | $0.0B |
| SG&A Expense | $0.7B | $0.2B | $0.2B | $0.2B | $0.1B | $0.1B | $0.2B | $0.1B |
| Operating Income | $0.5B | $0.1B | $0.1B | $0.6B | $0.5B | $0.5B | $0.5B | $0.5B |
| Net Income | $0.3B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B |
| EPS (Basic) | $4.13 | $1.02 | $0.84 | $1.34 | $0.83 | $0.70 | $1.51 | $0.78 |
| EPS (Diluted) | $4.11 | $1.01 | $0.83 | $1.32 | $0.82 | $0.69 | $1.48 | $0.77 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $6.7B | $6.4B | $6.5B | $5.8B | $5.2B | $5.0B | $4.9B | $4.4B |
| Current Assets | $2.6B | $2.5B | $2.6B | $2.5B | $2.2B | $2.0B | $1.9B | $1.7B |
| Cash & Equivalents | $0.4B | $0.4B | $0.4B | $0.3B | $0.3B | $0.3B | $0.2B | $0.1B |
| Total Liabilities | — | — | — | — | — | — | $2.9B | — |
| Current Liabilities | $0.9B | $0.8B | $1.5B | $1.0B | $0.9B | $0.8B | $0.7B | $0.7B |
| Stockholders' Equity | $3.2B | $2.8B | $2.6B | $2.3B | $2.3B | $2.2B | $1.9B | $1.6B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.6B | $0.5B | $0.5B | $0.5B | $0.4B | $0.6B | $0.6B | $0.3B |
| Investing Cash Flow | $-0.1B | $-0.3B | $-0.8B | $-0.6B | $-0.2B | $-0.2B | $-0.4B | $-0.9B |
| Capital Expenditures | — | — | — | $0.2B | $0.1B | $0.1B | $0.1B | $0.1B |
| Financing Cash Flow | $-0.4B | $-0.2B | $0.3B | $0.2B | $-0.3B | $-0.3B | $-0.1B | $0.6B |